NASDAQ
MBX Biosciences, Inc. Common Stock (MBX) has a free cash flow growth of -8.12% as of Friday, May 29, 2026. This represents a 13.45% decrease compared to its 12-month average of -7.16%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.